The Rise and Fall of the Age of Psychopharmacology (Paperback)

The Age of Psychopharmacology began with a brilliant rise in the 1950s, when for the first time science entered the study of drugs that affect the brain and mind. But, esteemed historian Edward Shorter argues that there has been a recent fall, as the field has seen its drug offerings impoverished and its diagnoses distorted by the "Diagnostic and Statistical Manual of Mental Disorders." The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as "major depression," have strayed increasingly from the real disorders of most patients. Behind this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.

General

Imprint:	Oxford UniversityPress
Country of origin:	United States
Release date:	November 2021
Authors:	Edward Shorter (Professor of Psychiatry and History of Medicine)
Dimensions:	234 x 155 x 25mm (L x W x T)
Format:	Paperback
Pages:	352
ISBN-13:	978-0-19-757443-0
Categories:	Books > Medicine > General issues > History of medicine Books > Medicine > Other branches of medicine > Psychiatry Books > Medicine > Other branches of medicine > Pharmacology > General
LSN:	0-19-757443-2
Barcode:	9780197574430

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!